|
Our focus on early stage trials allows us unique insight into the most prevalent challenges at this phase of testing. We have strategically built an infrastructure, methodology and facility that meet those needs.
Our business model focuses on Phase I/IIa clinical trials, including:
- First-In-Human Studies
- Single Dose, Multi-Dose, Ascending Dose
- Pharmacokinetic/ Pharmacodynamic (PK/PD)/Dose/Concentration
- Drug-Drug Interaction and Food Effect Studies
- Novel Delivery Systems
- Special Patient Populations
- Proof-of-Concept Studies
- Bioavailability/Bioequivalence
Our staff's experience in clinical trials encompasses a broad spectrum of therapeutic areas, including:
- CNS
- Cardiovascular
- Respiratory
- Gastrointestinal
- Hormone
- Urology
- Dermatology
- Oncology
- Antihistaminic
- Antibiotic agents
- Biologicals
- Alternative Medicines
SNBL CPC is a trusted partner prepared to support your research needs. We provide:
- Capacity Available Guarantee™
- Dedicated Phase I Project Management Team
- Rapid set-up program
- Flexible reporting formats and real-time tracking
- Expedited sample turnaround
- Flexible trial protocol and configuration
- Real Time Reporting and Advanced Data Management
- Quality Assurance
|
Print